# Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1

> **NCT02605265** · PHASE3 · COMPLETED · sponsor: **Fudan University** · enrollment: 356 (actual)

## Conditions studied

- Locally Advanced Rectal Cancer

## Interventions

- **RADIATION:** Radiation
- **DRUG:** Capecitabine
- **DRUG:** Irinotecan
- **DRUG:** Oxaliplatin

## Key facts

- **NCT ID:** NCT02605265
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2017-12
- **Final completion:** 2023-06
- **Target enrollment:** 356 (ACTUAL)
- **Last updated:** 2025-08-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02605265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02605265, "Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02605265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*